[{"Assets_0_Q2_USD":359219000.0,"EarningsPerShareBasic_1_Q2_USD":0.23,"EarningsPerShareBasic_2_Q2_USD":0.33,"EarningsPerShareDiluted_2_Q2_USD":0.33,"EarningsPerShareDiluted_1_Q2_USD":0.23,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6530000.0,"NetIncomeLoss_1_Q2_USD":2681000.0,"NetIncomeLoss_2_Q2_USD":3833000.0,"StockholdersEquity_0_Q2_USD":176546000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":11659000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":11667000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":11536000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":11546000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]